We have increased our forecast again for revenue from products launched in 2021.
Sales in Asia increased 20% year over year and 19% organically, driven by strong diamide sales across the region as well as pricing actions.
Guidance for Q4 implies year over year revenue growth of 19% at the midpoint on a reported basis with no FX impact anticipated.
Our 2021 revenue forecast remains in the range of $4.9 billion to $5.1 billion, an increase of 8% at the midpoint versus 2020.
Our 2021 revenue forecast remains in the range of $4.9 billion to $5.1 billion, an increase of 8% at the midpoint versus 2020.
Adjusted earnings were $1.43 per diluted share in the quarter, an increase of 17% versus Q3 2020.
We are raising FMC's full year 2021 earnings guidance to the range of $6.59 to $6.99 per diluted share, a year over year increase of 10% at the midpoint, reflecting the impact of share repurchases completed year to date.
